GO
Loading...

Allergan CEO: Restructuring & unlocking value

Wednesday, 9 Jul 2014 | 6:40 PM ET

David Pyott, Allergan chairman and CEO, discusses its restructuring efforts to unlock value for investors and questions the sustainability of Valeant's business model.